Project Grant R43EY033569
Award Date
6/1/22
Completion Date
11/30/23
Dollars Obligated
$604K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Albuquerque, NM 87106, USA
Similar Awards
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), is providing $306,462 to Ifocus Imaging LLC to develop a software platform called OCT-ART-DR. The platform will automate the diagnosis and staging of diabetic retinopathy using optical coherence tomography angiography (OCTA) imaging and artificial intelligence. The key products to be delivered under this award include: 1) Improved AI-based segmentation of OCTA image...
This federal Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) provides $881,796 to Siloam Vision, Inc. to develop two advanced, laser-based, AI-enabled retinal imaging systems. The key innovations are: A wider field-of-view camera design that can be paired with either a scanning laser ophthalmoscope (SLO) or optical coherence tomography (OCT) system, offering 2D or 3D imaging, respectively. This aims to address an unmet need in retinopathy...
The National Eye Institute (NEI) awarded a $745,607 Project Grant (CFDA 93.867 - Vision Research) to Retivue LLC in Charlottesville, Virginia to develop the RETIVUE ENTIREEYE - a handheld, high-resolution, non-contact, wide-field retinal screening camera for premature and healthy newborn babies. The device utilizes a novel scanning light module and high-speed photography to capture a single, seamless, diagnostic-quality image of the entire infant eye, overcoming limitations of existing...
This Project Grant award of $580,331 from the National Eye Institute (CFDA 93.867 - Vision Research) aims to develop a deep learning-based diagnostic tool for retinopathy of prematurity (ROP), a leading cause of childhood blindness. The key products and services to be delivered under this award include: Optimizing and testing an animal-to-human (A2H) model to augment the training dataset for the deep learning-based ROP diagnostic model, using existing and newly acquired longitudinal animal ROP...
The National Eye Institute (NEI) awarded a $295,766 Project Grant (CFDA 93.867 - Vision Research) to Ther-Ai LLC, located in Oviedo, FL, to develop a smartphone application called ILIGN. The goal of this project is to create a rapid, non-invasive, and accurate artificial intelligence-driven system to pre-screen for ocular misalignment (strabismus), a leading cause of preventable blindness in children. The expected outcome is a software platform that allows untrained end-users to diagnose...
Aisight Health Inc. received a $479,580 Project Grant award from the National Institutes of Health's National Eye Institute to develop artificial intelligence tools to identify rapid glaucoma progression. The goal is to use machine learning models trained on over a decade of optical coherence tomography images, visual field tests, and clinical records for more than 9,000 glaucoma patients to more accurately and quickly determine which patients are likely to experience rapid vision loss from...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), provides $179,964 to the University of California, Irvine to develop innovative deep learning-based biomarkers and predictive models for the diagnosis and management of optic neuropathies using optical coherence tomography (OCT) imaging. The project aims to leverage advanced computational techniques like deep learning, neural fields, and geometric modeling to extract...
This Project Grant award of $869,528 from the National Eye Institute (NEI), part of the NIH Vision Research program (CFDA 93.867), aims to develop an Automated Quantitative Ulcer Analysis (AQUA) algorithm and a point-of-care decision tool to rapidly identify the causative organism type in cases of microbial keratitis, a leading cause of worldwide blindness. The project has four key objectives: 1) Identify risk factors associated with organism types, 2) Create and validate a novel machine...
This Project Grant award from the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) will fund the development of a new wide-field visible-light optical coherence tomography (WF-VIS-OCT) device to evaluate the oxygen-induced retinopathy (OIR) model in rats. The $623,090 award, effective September 1, 2024, will support the Oregon Health & Science University in three main efforts: 1) developing the WF-VIS-OCT system with 5-mm transverse resolution over a...
This $433,841 federal Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports the development of computational methods and deep learning models to analyze imaging data and identify biomarkers for age-related macular degeneration (AMD). The goal is to improve understanding of AMD disease progression and response to treatment. Specifically, the project will develop deep neural network models to analyze optical coherence tomography,...